Statistics
Publications
6
Citations
96
H-Index
6
Active since
2013
Hiroyuki Yoshitsugu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, clinical pharmacology, and pharmacokinetics.
Publications per year
2013–2022
6
6
BMS-911543, A Selective JAK2 Inhibitor: A Multicenter Phase 1/2a Study In Myelofibrosis
Animesh Pardanani, Andrew W. Roberts, John F. Seymour et al. · Blood · 2013 · 27 citations
Medicine, Hematology, Pharmacology +10
Keisuke Nakamura, Katsukuni Fujimoto, Chihiro Hasegawa et al. · Clinical and Translational Science · 2022 · 17 citations · Full text
Kazuhiko Asari, Mikio Ishii, Hiroyuki Yoshitsugu et al. · Clinical Pharmacology in Drug Development · 2022 · 12 citations
Makoto Kakara, Kajal Larson, Hwa-ping Feng et al. · Journal of Infection and Chemotherapy · 2018 · 11 citations · Full text
1–5 of 6